Indication
Elder
3 clinical trials
3 products
Clinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate Pharmacokinetics, Safety and Tolerability of RAY1216 in Elder ParticipantsStatus: Completed, Estimated PCD: 2023-09-20
Product
LeritrelvirClinical trial
A Single Center, Non-randomized, Open-label Phase I Study to Investigate the Pharmacokinetics and Safety of SIM0417/Ritonavir After Single Dose Administration in Healthy Elderly SubjectsStatus: Recruiting, Estimated PCD: 2023-09-30
Product
SIM0417/RitonavirProduct
ZSP1273Clinical trial
A Phase I Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate Pharmacokinetics, Safety and Tolerability of ZSP1273 in Elder ParticipantsStatus: Completed, Estimated PCD: 2023-11-01